ConductScience.org, home

Paper39543737

Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer.

Zhang C and 7 others. J Ovarian Res, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer. Papers, record 39543737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39543737

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer.
PubMed
Journal
J Ovarian Res
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.85, provisional
iCite
Revised in PubMed
2024-11-17
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang CChen
2Cheng HHongyan
3Dou SSha
4Wang YYuanfen
5Ye XXue
6Cui HHeng
7Chang XXiaohong
8Li YYi

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CetuximabMajor topic
Optical ImagingMajor topic
Carcinoma, Ovarian EpithelialMajor topic
Fluorescent DyesMajor topic
Ovarian NeoplasmsMajor topic
ErbB ReceptorsMajor topic
Female
Humans
Animals
Cell Line, Tumor
Mice
Xenograft Model Antitumor Assays
Mice, Nude
Disease Models, Animal

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No.2016YFA0201400National Key Research and Development Program of ChinaPubMed
No. 2022YFC2704204National Key Research and Development Program of ChinaPubMed
No. 7222202Natural Science Foundation of Beijing MunicipalityPubMed
No. 7222204Natural Science Foundation of Beijing MunicipalityPubMed

Source PubMed

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129721094Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.Theranostics2018https://conductscience.org/library/papers/29721094PubMed
223591395Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.Biomaterials2013https://conductscience.org/library/papers/23591395PubMed
332660222EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells.Iran Biomed J2020https://conductscience.org/library/papers/32660222PubMed
436070540A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).J Clin Oncol2023https://conductscience.org/library/papers/36070540PubMed
526110901The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer.PLoS One2015https://conductscience.org/library/papers/26110901PubMed
625904751Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.Clin Cancer Res2015https://conductscience.org/library/papers/25904751PubMed
721909139Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.Oncogene2012https://conductscience.org/library/papers/21909139PubMed
831564810Evaluation of COC183B2 antibody targeting ovarian cancer by near-infrared fluorescence imaging.Chin J Cancer Res2019https://conductscience.org/library/papers/31564810PubMed
911562388Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.J Natl Cancer Inst2001https://conductscience.org/library/papers/11562388PubMed
1023144806Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.PLoS One2012https://conductscience.org/library/papers/23144806PubMed
1126595119A small-molecule dye for NIR-II imaging.Nat Mater2016https://conductscience.org/library/papers/26595119PubMed
1235420035NIR-II Navigation with an EGFR-Targeted Probe Improves Imaging Resolution and Sensitivity of Detecting Micrometastases in Esophageal Squamous Cell Carcinoma Xenograft Models.Mol Pharm2022https://conductscience.org/library/papers/35420035PubMed
1335485744Outcome of near-infrared fluorescence-navigated pulmonary metastasectomy for hepatocellular carcinoma.Eur J Cardiothorac Surg2022https://conductscience.org/library/papers/35485744PubMed
1435517713Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW.Mol Imaging2022https://conductscience.org/library/papers/35517713PubMed
1531362825A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.Gynecol Oncol2019https://conductscience.org/library/papers/31362825PubMed
1636207638New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue.Eur J Nucl Med Mol Imaging2023https://conductscience.org/library/papers/36207638PubMed
1737041632Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/37041632PubMed
1818222534Folate receptor alpha as a tumor target in epithelial ovarian cancer.Gynecol Oncol2008https://conductscience.org/library/papers/18222534PubMed
1933765422Real-time fluorescence imaging in intraoperative decision making for cancer surgery.Lancet Oncol2021https://conductscience.org/library/papers/33765422PubMed
2030664215Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway.Mol Med Rep2019https://conductscience.org/library/papers/30664215PubMed

See all 39 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42198268Emerging Near-Infrared Targeted Imaging Pharmaceutics for Ovarian Cancer.Pharmaceutics2026https://conductscience.org/library/papers/42198268PubMed
41036172In vivo 3D imaging of ovarian cancer outgrowth in transgenic mouse model with optical coherence tomography.J Biomed Opt2025https://conductscience.org/library/papers/41036172PubMed
40661211Molecular imaging using (nano)probes: cutting-edge developments and clinical challenges in diagnostics.RSC Adv2025https://conductscience.org/library/papers/40661211PubMed
40293497Exploring the mechanisms of cinobufotalin in ovarian cancer treatment: An integrated approach combining network pharmacology, molecular docking and RNA Sequencing.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40293497PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39543737

GET https://conductscience.org/api/papers/v1/39543737/references?page=2